McKesson
MCK
#275
Rank
$50.14 B
Marketcap
$348.88
Share price
-0.57%
Change (1 day)
76.02%
Change (1 year)
McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools.

P/E ratio for McKesson (MCK)

P/E ratio as of October 2022 (TTM): 36.6

According to McKesson's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 36.5647. At the end of 2021 the company had a P/E ratio of 27.6.

P/E ratio history for McKesson from 2001 to 2022

PE ratio at the end of each year

Year P/E ratio Change
202127.6-526.7%
2020-6.48-77.19%
2019-28.4-65.8%
2018-83.1-1311.15%
20176.86-58.3%
201616.4-29.29%
201523.3-16.97%
201428.0

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.